Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated rats.
Poli
A
A
Center E. Grossi Paoletti, Chemotherapy and Pharmawgnosy Chairs, University of Milano, 20129 Milano, Italy.
Franceschini
G
G
Puglisi
L
L
Sirtori
C R
CR
D000818:Animals; D001059:Apoproteins / Q000737:chemistry*; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood*; D003720:Densitometry; D003921:Diabetes Mellitus, Experimental / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D005215:Fasting; D006863:Hydrogen-Ion Concentration; D007525:Isoelectric Focusing; D008074:Lipoproteins / Q000097:blood* / Q000648:ultrastructure; D008297:Male; D000072317:Polychlorinated Dibenzodioxins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013311:Streptozocin / Q000633:toxicity; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014461:Ultracentrifugation
D001059:Apoproteins; D008076:Cholesterol, HDL; D008074:Lipoproteins; D000072317:Polychlorinated Dibenzodioxins; D014280:Triglycerides; D013311:Streptozocin; D002784:Cholesterol